NCT00333112 A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. Status COMPLETED Phase PHASE4
NCT00333073 Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence Status COMPLETED Phase NA
NCT00323635 A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. Status TERMINATED Phase PHASE4
NCT00323245 Regaining Bladder Control in Postmenopausal Women With Osteoporosis Status COMPLETED Phase NA
NCT00304499 Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00293839 Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder Status COMPLETED Phase PHASE3
NCT00290563 Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) Status COMPLETED Phase PHASE2
NCT00277095 ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males Status COMPLETED Phase NA
NCT00270998 ATLAS: Ambulatory Treatments for Leakage Associated With Stress Status COMPLETED Phase PHASE3
NCT00269724 A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00262496 Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. Status WITHDRAWN Phase PHASE2
NCT00253006 Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium Status TERMINATED Phase N/A
NCT00239824 Pelvic Floor Muscle Training to Treat Urinary Incontinence After Radical Prostatectomy Status COMPLETED Phase NA
NCT00238680 Programmable Timer in the Bladder Rehabilitation Treatment of OAB Status COMPLETED Phase NA
NCT00231790 A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007) Status COMPLETED Phase PHASE2